Keytru­da be­fore and af­ter lung can­cer surgery cuts re­lapse risk by 42%, but doesn’t im­prove sur­vival: #AS­CO23

CHICA­GO — Mer­ck has found par­tial suc­cess with its lat­est ef­fort to more ag­gres­sive­ly treat ear­li­er stages of lung can­cer.
On Sat­ur­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.